📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Strides Pharma to Acquire Sandoz Generic Brands in Africa for USD 12 Million
Strides Pharma Science, through its subsidiary, has entered into an agreement to acquire and in-license a portfolio of branded generic products from Sandoz across Sub-Saharan Africa. The deal involves an upfront payment of USD 12 million plus variable royalty payments based on future sales. This strategic move targets four key markets—Nigeria, Kenya, Ghana, and Western Sahara—and is expected to position Strides among the top five pharmaceutical companies in the region. The transaction is slated for completion by the end of September 2026.
Key Highlights
Upfront consideration of USD 12 million for acquisition and in-licensing of Sandoz brands.
Targets high-growth Sub-Saharan African markets including Nigeria, Kenya, Ghana, and Western Sahara.
Expected to elevate Strides to a top 5 pharmaceutical player in the SSA region by sales volume.
Portfolio includes established brands in anti-infective, cardiovascular, and dermatology segments.
Transaction includes a corporate guarantee from a Singapore subsidiary to secure payment obligations.
💼 Action for Investors
Investors should monitor the integration of these brands as it significantly strengthens Strides' footprint in the African market. The deal is a positive step toward scaling their international branded generics business, though the full financial impact will only be visible after Q2 FY27.
Strides Pharma to Acquire Sandoz Generic Brands in Africa for USD 12 Million
Strides Pharma's subsidiary has entered into a definitive agreement with Sandoz to acquire and in-license a portfolio of branded generic products across Sub-Saharan Africa. The deal involves an upfront payment of USD 12 million plus ongoing royalties, targeting key markets including Kenya, Nigeria, and Ghana. This acquisition is strategically designed to position Strides among the top five pharmaceutical companies in the region. The portfolio includes established brands in anti-infective, cardiovascular, and dermatology segments, with several products generating over USD 1 million in annual sales.
Key Highlights
Upfront consideration of USD 12 Million for acquisition and in-licensing of Sandoz brands
Targeting four key Sub-Saharan Africa markets: Western Sahara, Ghana, Nigeria, and Kenya
Expected to elevate Strides to a top 5 pharmaceutical company in the SSA region by sales
Portfolio includes multiple brands with individual annual sales exceeding USD 1 Million
Transaction closure is anticipated by the end of Q2 FY27 (September 2026)
💼 Action for Investors
Investors should view this as a positive strategic move to scale the company's high-growth African business. Monitor the integration of these brands and their contribution to the company's international revenue starting late 2026.
Strides Pharma Acquires Sandoz's SSA Branded Generic Portfolio for $12 Million
Strides Pharma Science's subsidiary has entered into an agreement to acquire and in-license Sandoz's branded generic portfolio across Sub-Saharan Africa for an initial consideration of $12 million. The acquisition spans 13 countries, including key markets like Nigeria, Kenya, and Ghana, focusing on anti-infective, cardiovascular, and dermatology segments. This move is expected to more than double Strides' presence in the region and position it as a top five pharmaceutical player in Sub-Saharan Africa. The transaction is funded via internal accruals and is projected to be EPS-accretive with a closing date expected by the end of Q2 FY27.
Key Highlights
Acquisition of Sandoz's branded generic portfolio in Sub-Saharan Africa for $12 million initial consideration.
The deal more than doubles Strides' regional presence, targeting a top 5 market position in Sub-Saharan Africa.
Portfolio includes multiple brands with individual annual sales exceeding $1 million across three therapeutic segments.
Transaction is expected to be EPS-accretive and is slated for completion by September 30, 2026.
Strategic alignment with 'in Africa for Africa' goal to make Ex-US markets match the scale of the US business.
💼 Action for Investors
Investors should monitor the successful integration of these brands as they offer higher-margin branded sales and significant cross-selling opportunities in the fast-growing African market. The low acquisition cost relative to the scale gained makes this a highly capital-efficient growth move.
Five-Star Business Finance Board Approves INR 5,000 Crore Fundraise via NCDs
The Board of Directors of Five-Star Business Finance has approved a significant fundraising limit of up to INR 5,000 Crores. This capital will be raised through the issuance of Non-Convertible Debentures (NCDs) via private placement in one or more tranches. The move is intended to bolster the company's capital base and support its ongoing lending operations. Specific details regarding interest rates and tenures will be disclosed at the time of each allotment.
Key Highlights
Board approved a fundraising limit of up to INR 5,000 Crores through NCDs.
Issuance will be conducted via private placement in one or more tranches or series.
The NCDs are proposed to be listed on stock exchanges to be named at allotment.
The board meeting concluded on March 17, 2026, with immediate approval of the limits.
💼 Action for Investors
Investors should monitor the coupon rates of future tranches to assess the company's cost of funds and its impact on net interest margins. The large fundraising limit indicates a strong growth outlook for the company's loan portfolio.
Prostarm Info Systems Declared L-1 Bidder for INR 90.44 Crore WBMSC Contract
Prostarm Info Systems Limited has been declared the L-1 bidder for a significant domestic contract from West Bengal Medical Services Corporation (WBMSC) worth INR 90.44 Crores. The project involves the supply, installation, and commissioning of 6 KVA online UPS systems and batteries across 3,439 healthcare facilities throughout West Bengal. The contract is funded under the XV Finance Commission and is expected to be completed within a 180-day timeframe. This order represents a substantial boost to the company's order book and revenue visibility for the next two quarters.
Key Highlights
Declared L-1 bidder for a contract valued at INR 90.44 Crores from WBMSC Kolkata
Scope covers 3,439 locations including 3,000 Sub Centers and 439 Urban Health Centers
Execution timeline is strictly set at 180 days for supply and commissioning
Project involves 6 KVA single-phase input/output online UPS systems including batteries
💼 Action for Investors
Investors should monitor the formal award of the contract and the company's execution progress over the next six months, as this large order could significantly impact short-term earnings.
Prostarm Secures INR 6.71 Cr Order from SAIL for 2 MW Roof Top Solar Project
Prostarm Info Systems Limited has received a Letter of Acceptance (LOA) from Steel Authority of India Limited (SAIL) for a solar infrastructure project. The contract involves the supply, installation, and commissioning of a 2 MW (AC) Roof Top Solar PV System at various plant buildings. Valued at INR 6.71 Crores, the project is slated for completion within a 12-month timeframe. This domestic order from a major PSU enhances the company's credentials in the renewable energy sector.
Key Highlights
Received a Letter of Acceptance from Steel Authority of India Limited (SAIL) worth INR 6.71 Crores
Scope includes supply, installation, and commissioning of a 2 MW (AC) Roof Top Solar PV System
Project execution period is defined as 12 months
The order is domestic and was secured in the normal course of business
💼 Action for Investors
Investors should view this as a positive development that strengthens the order book and validates the company's technical capabilities with a major PSU client. Monitor the execution progress over the next 12 months to ensure timely revenue recognition.
Prostarm Secures INR 6.71 Cr Solar Project Order from SAIL for 2 MW System
Prostarm Info Systems Limited has received a Letter of Acceptance (LOA) from Steel Authority of India Limited (SAIL) for a 2 MW Roof Top Solar PV project. The contract is valued at INR 6.71 Crores and involves the supply, installation, and commissioning of the system across various plant buildings. The project is scheduled for execution over a 12-month period. This domestic order from a major PSU strengthens the company's portfolio in the renewable energy sector.
Key Highlights
Awarded a 2 MW (AC) Roof Top Solar PV System project by SAIL
Total contract value is approximately INR 6.71 Crores
Execution timeline for the project is 12 months
Scope includes supply, installation, and commissioning at various plant buildings
💼 Action for Investors
Investors should view this as a positive development that enhances the company's order book and credibility with large PSUs. Monitor the timely execution of the project and its impact on upcoming quarterly margins.
Blue Star Launches 125 New AC Models for 2026, Targets 1.8M Unit Capacity
Blue Star has unveiled a comprehensive range of 125 new Room Air Conditioner models for the 2026 summer season, all compliant with the latest BEE energy standards. The company is scaling its manufacturing capacity from 1.4 million to 1.8 million units to meet a projected industry demand of 30 million units by FY30. Key product innovations include 'Super Energy-Efficient ACs' with an ISEER of 6.25 and heavy-duty models capable of cooling at 56°C. The expansion strategically targets high-growth Tier 3-5 markets and includes a robust range of commercial refrigeration solutions for sectors like healthcare and quick commerce.
Key Highlights
Launched 125 new Room AC models including the premium 'Iconia' range and 'Super Energy-Efficient' units with 6.25 ISEER.
Manufacturing capacity currently at 1.4 million units, with scalability up to 1.8 million units across three plants.
Distribution network expanded to 900 towns with over 10,000 retail outlets and 2,100 service partners.
Heavy-duty ACs designed to maintain full cooling capacity at 43°C and operate in temperatures up to 56°C.
Strategic focus on Tier 3, 4, and 5 markets to capture first-time buyers and replacement demand.
💼 Action for Investors
Investors should monitor market share gains in under-penetrated Tier 3-5 cities and the successful ramp-up of the Sri City facility. The stock remains a strong play on India's rising cooling demand and energy efficiency trends.
Blue Star Seeks Shareholder Approval for Key Leadership Appointments and Re-appointments
Blue Star Limited has issued a postal ballot notice to seek shareholder approval for three significant board positions. The company proposes the re-appointment of Mr. B Thiagarajan as Managing Director until May 2027 and the appointment of Mr. Mohit Sud as Executive Director for the Unitary Cooling Products Group for a five-year term. Additionally, Mr. M S Unnikrishnan is proposed as an Independent Director for a five-year term effective January 2026. These appointments are intended to ensure leadership continuity and functional expertise in core business segments.
Key Highlights
Re-appointment of Mr. B Thiagarajan as Managing Director from April 1, 2026, to May 24, 2027.
Appointment of Mr. Mohit Sud as Executive Director for a 5-year term starting April 1, 2026.
Appointment of Mr. M S Unnikrishnan as Independent Director for a 5-year term from Jan 29, 2026, to Jan 28, 2031.
Remote e-voting period scheduled from March 2, 2026, to March 31, 2026.
Final results of the postal ballot to be declared on or before April 2, 2026.
💼 Action for Investors
Investors should note the leadership continuity in the Managing Director role and the addition of specialized leadership for the cooling products group. No immediate action is required as these are standard governance procedures to formalize management structure.
Prostarm Secures INR 13.43 Crore Solar Project from South Eastern Railway
Prostarm Info Systems Limited has received a Letter of Acceptance from South Eastern Railway for a solar power plant project. The contract is valued at INR 13.43 Crores and involves the supply, installation, and erection of the plant at SRC Jurisdiction (Phase 2). The project is scheduled for completion within 12 months and includes a 5-year comprehensive maintenance contract. This order strengthens the company's order book and highlights its growing footprint in the renewable energy sector.
Key Highlights
Awarded a contract worth INR 13.43 Crores by South Eastern Railway
Scope includes supply, installation, and erection of a solar power plant
Project execution timeline is 12 months from the date of LOA
Includes a 5-year Comprehensive Maintenance Contract (CMC) post-installation
The contract was secured in the normal course of business for Phase 2 of the SRC Jurisdiction
💼 Action for Investors
Investors should view this as a positive development for revenue visibility and track the company's execution efficiency over the 12-month period. The 5-year maintenance component provides a small but steady stream of recurring service income.
Star Cement Subsidiary Starts Commercial Production at 2.0 MTPA Grinding Unit in Assam
Star Cement Limited's subsidiary, Star Cement North East Limited, has successfully commenced commercial production at its new grinding unit in Cachar, Assam, as of February 20, 2026. The new facility adds a substantial 2.0 MTPA (Million Tonnes Per Annum) to the company's existing production capacity. This expansion is strategically located to serve the high-demand Northeast Indian market. The operationalization of this unit is expected to drive volume growth and enhance the company's regional market share in the near term.
Key Highlights
Commencement of commercial production at a new 2.0 MTPA grinding unit in Cachar, Assam.
The project was executed through the subsidiary company, Star Cement North East Limited.
Operations officially began on February 20, 2026, following successful setup.
The expansion significantly boosts the company's total cement grinding capacity in its core Northeast market.
💼 Action for Investors
Investors should consider this a positive development for long-term growth as it increases production capacity by 2.0 MTPA. Monitor the next few quarterly results to see the impact of this new capacity on revenue and EBITDA margins.
IndoStar Q3 PAT at ₹8.25 Cr; 9M Profit Surges to ₹554 Cr on NHFPL Divestment Gain
IndoStar Capital Finance reported a standalone Profit After Tax (PAT) of ₹8.25 crore for Q3 FY26, down from ₹11.41 crore in the previous year's corresponding quarter. The nine-month (9M FY26) PAT reached a significant ₹554.16 crore, primarily due to a one-time exceptional gain of ₹1,175.95 crore from the sale of its subsidiary, Niwas Housing Finance. Total revenue from operations for the quarter stood at ₹346.33 crore, showing a slight decline year-on-year. The company also accounted for a ₹4.8 crore impact on employee expenses following the notification of new Government Labour Codes.
Key Highlights
Standalone PAT for Q3 FY26 stood at ₹8.25 crore compared to ₹11.41 crore in Q3 FY25.
Exceptional gain of ₹1,175.95 crore recorded in 9M FY26 from the divestment of Niwas Housing Finance (NHFPL).
Finance costs decreased to ₹137.13 crore in Q3 FY26 from ₹192.98 crore in the same quarter last year.
Impairment on financial instruments rose to ₹76.92 crore in Q3 FY26 from ₹47.94 crore YoY.
Stressed loans with an aggregate principal of ₹343.66 crore were transferred to ARCs during the nine-month period.
💼 Action for Investors
Investors should monitor how the company deploys the substantial capital gains from the NHFPL sale to drive growth in its core lending segments. While operational profitability remains modest, the reduction in finance costs and a cleaner balance sheet post-ARC transfers are positive signs for long-term stability.
Prostarm Q3 FY26 Revenue Jumps 110% to ₹161 Cr; Order Book Robust at ₹946 Cr
Prostarm Info Systems reported a massive 110% YoY revenue growth in Q3 FY26, reaching INR 161 crores, driven by large-scale project executions. The company's order book stands at a robust INR 946 crores, providing strong visibility for the next 18 months. Profitability also saw a significant jump, with PAT rising 101% YoY to INR 15 crores. Additionally, the company has become effectively net debt-free and is nearing the commissioning of a 1.2 GW BESS facility in Jhajjar.
Key Highlights
Q3 FY26 revenue grew 110% YoY to ₹161 crores, with PAT increasing 101% to ₹15 crores.
Current order book stands at ₹946 crores across 91 projects, with an additional ₹775 crores in the bid pipeline.
Long-term debt reduced to ₹1.5 crores, making the company effectively net debt-free.
New 1.2 GW BESS manufacturing facility in Jhajjar is expected to be operational by Q4 FY26.
Management guides for 20-25% revenue growth for the full year FY26.
💼 Action for Investors
Investors should monitor the commissioning of the Jhajjar BESS facility and the execution of the large order book, which represents over 3x the current 9M revenue. The stock remains attractive due to its net debt-free status and strong growth trajectory in the energy storage sector.
Prostarm Q3 FY26 PAT Doubles to ₹15 Cr; Order Book Surges to ₹946 Cr
Prostarm Info Systems reported a stellar Q3 FY26 with revenue growing 110% YoY to ₹161 crores and PAT increasing 101% to ₹15 crores. The company's order book stands robust at ₹946 crores, providing strong revenue visibility for the next 18 months. Management highlighted that the company is now effectively net debt-free, with long-term debt reduced to just ₹1.5 crore. Expansion plans are on track with a new 1.2 GW BESS facility in Jhajjar expected to be operational by Q4 FY26.
Key Highlights
Q3 Revenue surged 110% YoY to ₹161 crores, driven by large-scale project executions.
Order book reached ₹946 crores across 91 projects, with an additional ₹775 crores in the bidding pipeline.
Company is effectively net debt-free as long-term debt decreased from ₹3.4 crore to ₹1.5 crore.
New 1.2 GW BESS manufacturing facility in Jhajjar is nearing commissioning in Q4 FY26.
EBITDA margins for Q3 stood at 12.65%, with management targeting a sustainable range of 12-15%.
💼 Action for Investors
Investors should monitor the commissioning of the Jhajjar facility and the conversion of the ₹775 crore bid pipeline into firm orders. The strong order book and debt-free status make it a compelling growth story in the power electronics and energy storage sector.
Strides Pharma Subsidiary Completes 100% Acquisition of Neviton Softech for ₹21.77 Cr
Strides Pharma's wholly-owned subsidiary, Arco Lab, has acquired the remaining 50% stake in Neviton Softech for approximately ₹21.77 crores (Euro 2 million). Neviton, which specializes in IT services and IoT-based engineering solutions, reported a turnover of ₹27.08 crores and a PAT of ₹4.26 crores for FY25. This acquisition consolidates Neviton as a step-down subsidiary, following a phased investment strategy that began in 2022. The move is strategically aimed at enhancing Strides' internal digitization and driving operational cost efficiencies.
Key Highlights
Acquisition of the final 50% equity interest in Neviton Softech for a cash consideration of ~₹21.77 crores.
Neviton reported a steady financial performance with FY25 turnover of ₹27.08 crores and PAT of ₹4.26 crores.
Target company specializes in high-tech areas including IoT devices and real-time data integration for engineering solutions.
Strategic integration with Arco Lab is expected to yield significant cash savings and enable better group-wide digitization.
💼 Action for Investors
This is a strategic bolt-on acquisition that strengthens the company's internal IT and digital capabilities at a reasonable valuation. Investors should monitor how these technological synergies contribute to long-term operational margin improvements.
IndoStar Q3 FY26: Disbursements Up 20% QoQ to ₹1,117 Cr; Vehicle Finance Leads Growth
IndoStar Capital Finance reported a 20% sequential growth in disbursements to ₹1,117 crores for Q3 FY26, driven primarily by the vehicle finance segment. The company's total AUM reached ₹7,692 crores, while Net Interest Income grew 16.1% year-on-year to ₹209 crores. Asset quality showed significant improvement, with delinquency levels in the 2025 cohort being 50% lower than previous years. Management is focusing on retail-led growth through used vehicle finance and Micro LAP, supported by a digital-first approach.
Key Highlights
Total disbursements rose 20% QoQ to ₹1,117 crores, with vehicle finance contributing ₹1,087 crores.
Net Interest Income (NII) increased by 16.1% YoY to ₹209 crores for the quarter.
Asset quality improved significantly, with the 2025 cohort showing 50% lower delinquency levels than previous cohorts.
Micro LAP segment AUM reached ₹128 crores with a collection efficiency near 100% and only 6 customers in 1+ DPD.
Completed preferential allotment of 2.5 crore shares to promoters and Florintree upon warrant conversion.
💼 Action for Investors
Investors should monitor the continued scale-up of the high-yield Micro LAP business and the impact of new leadership on vehicle finance margins. The improved asset quality of recent cohorts suggests a lower credit cost trajectory ahead.
Prostarm Info Systems Reports 9M FY26 Revenue of ₹2,813 Mn with ₹9,460 Mn Order Book
Prostarm Info Systems Limited showcased strong growth in its Q3 & 9M FY26 investor presentation, reporting an operating income of INR 2,813 Mn for the nine-month period. The company maintains a robust order book of INR 9,460 Mn, which is significantly higher than its annual revenue, providing high growth visibility. Key performance indicators remain healthy with an ROE of 27.82% and ROCE of 40.81%. Significant expansion is underway with a new 1.2 GWH BESS facility in Haryana expected to be operational by Q4-FY26 and a Gujarat unit in Q1-FY27.
Key Highlights
Total order book stands at a significant INR 9,460 Mn as of February 2026
Reported 9M-FY26 operating income of INR 2,813 Mn with an EBITDA margin of 12.55%
Strong historical growth with a 3-year Revenue CAGR of 26.97% and PAT CAGR of 38.41%
Expanding manufacturing footprint with a 1.2 GWH BESS unit in Haryana (Q4-FY26) and a new UPS unit in Gujarat (Q1-FY27)
Secured major BESS orders from Adani Electricity, Bihar State Power, and KPTCL
💼 Action for Investors
Investors should monitor the timely commissioning of the new BESS and UPS facilities, as these are critical for executing the massive ₹9,460 Mn order book. The company's entry into the high-growth BESS segment and its strong return ratios make it a key player to watch in the power conditioning space.
Melstar Reports Zero Revenue and ₹20.31 Lakh Loss in Q3 FY26; CFO Appointed
Melstar Information Technologies reported zero revenue for the quarter ended December 31, 2025, as it continues to struggle post-insolvency proceedings. The company recorded a net loss of ₹20.31 lakhs for the quarter, while the nine-month loss widened significantly to ₹118.41 lakhs from ₹29.95 lakhs in the previous year. Statutory auditors have issued a qualified opinion, raising concerns about the company's ability to continue as a 'going concern' given the lack of operations and reliance on future business licenses. Management has been restructured with the formal appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Independent Director.
Key Highlights
Reported zero revenue from operations and zero other income for both Q3 FY26 and the nine-month period.
Net loss for Q3 FY26 stood at ₹20.31 lakhs, compared to a loss of ₹23.07 lakhs in the same quarter last year.
Nine-month (9M) net loss surged to ₹118.41 lakhs, a sharp increase from the ₹29.95 lakh loss reported in 9M FY25.
Auditors issued a qualified conclusion citing the company's history of corporate insolvency and lack of current business activity.
Board approved the appointment of Raveendra Sangapu as CFO and Rose Mary Vase as an Additional Independent Director.
💼 Action for Investors
Investors should remain highly cautious as the company has no operational revenue and faces significant 'going concern' risks. The stock is speculative until there is clear evidence of business licenses being obtained and operations restarting.
Melstar Reports Zero Revenue in Q3 FY26; Appoints New CFO and Independent Director
Melstar Information Technologies reported zero revenue for the quarter ended December 31, 2025, resulting in a net loss of ₹20.31 lakhs. The company is currently in a post-insolvency phase under new management and is awaiting necessary business licenses to commence operations. Key leadership changes include the appointment of Mr. Raveendra Sangapu as CFO and Ms. Rose Mary Vase as an Independent Director. The statutory auditors have issued a qualified opinion, noting that the company's status as a going concern is dependent on the successful execution of its new business plan.
Key Highlights
Reported zero revenue from operations for both the quarter and nine-month period ended December 31, 2025.
Net loss for the quarter stood at ₹20.31 lakhs, while the nine-month loss reached ₹118.41 lakhs.
Appointed Ms. Rose Mary Vase as an Additional Independent Director for a five-year term.
Promoted Mr. Raveendra Sangapu to the position of Chief Financial Officer (KMP).
Auditors issued a qualified conclusion due to the company's history of insolvency and lack of current operational revenue.
💼 Action for Investors
Investors should exercise extreme caution as the company is currently non-operational and its future depends entirely on obtaining regulatory clearances to restart business activities. The stock remains highly speculative following its emergence from the Corporate Insolvency Resolution Process.
Melstar Reports Zero Revenue and ₹20.31 Lakh Net Loss in Q3 FY26; Appoints New CFO
Melstar Information Technologies reported zero revenue from operations for the quarter ended December 31, 2025, as it continues to await business licenses to restart operations. The company posted a net loss of ₹20.31 lakhs for the quarter, which is an improvement over the ₹53.84 lakhs loss in the preceding quarter. Statutory auditors have issued a qualified opinion, noting that the company's financial results are prepared on a 'going concern' basis despite historical insolvency proceedings and current lack of operations. The board also announced the appointment of Raveendra Sangapu as Chief Financial Officer and Rose Mary Vase as an Independent Director.
Key Highlights
Reported zero revenue from operations and zero other income for the quarter ended December 31, 2025.
Net loss for the quarter stood at ₹20.31 lakhs, compared to a loss of ₹23.07 lakhs in the same period last year.
Cumulative net loss for the nine-month period ended December 31, 2025, reached ₹118.41 lakhs.
Auditors highlighted a qualified conclusion regarding the 'going concern' status as the company is still awaiting licenses to commence business.
Board approved the appointment of Mr. Raveendra Sangapu as CFO and Ms. Rose Mary Vase as an Additional Independent Director.
💼 Action for Investors
Investors should remain highly cautious as the company has no operational revenue and is currently surviving on a 'going concern' assumption post-insolvency. It is advisable to wait for actual revenue generation and the receipt of necessary business licenses before considering any investment.